These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 26506444)

  • 21. Preferences for health outcomes and cost-utility analysis.
    Torrance GW
    Am J Manag Care; 1997 May; 3 Suppl():S8-20. PubMed ID: 10180342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Culturally adaptive storytelling method to improve hypertension control in Vietnam - "We talk about our hypertension": study protocol for a feasibility cluster-randomized controlled trial.
    Allison JJ; Nguyen HL; Ha DA; Chiriboga G; Ly HN; Tran HT; Phan NT; Vu NC; Kim M; Goldberg RJ
    Trials; 2016 Jan; 17():26. PubMed ID: 26762128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The study of management of hypertensive people aged 35 and over in communities in China].
    Zeng XY; Wang LM; Wang LH; Li YC; Zhang M; Jiang Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Nov; 47(11):1014-9. PubMed ID: 24507230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between health-state utilities and the SF-12 in a general population.
    Lundberg L; Johannesson M; Isacson DG; Borgquist L
    Med Decis Making; 1999; 19(2):128-40. PubMed ID: 10231075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of Barostim therapy for the treatment of resistant hypertension in European settings.
    Borisenko O; Beige J; Lovett EG; Hoppe UC; Bjessmo S
    J Hypertens; 2014 Mar; 32(3):681-92. PubMed ID: 24378998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting utility ratings for joint health States from single health States in prostate cancer: empirical testing of 3 alternative theories.
    Dale W; Basu A; Elstein A; Meltzer D
    Med Decis Making; 2008; 28(1):102-12. PubMed ID: 18057188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of noninvasive central blood pressure monitoring in the diagnosis of hypertension.
    Cheng HM; Pearson A; Sung SH; Yu WC; Chen CH; Karnon J
    Am J Hypertens; 2015 May; 28(5):604-14. PubMed ID: 25430695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of screening and optimal management for diabetes, hypertension, and chronic kidney disease: a modeled analysis.
    Howard K; White S; Salkeld G; McDonald S; Craig JC; Chadban S; Cass A
    Value Health; 2010; 13(2):196-208. PubMed ID: 19878493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health utilities in gynecological oncology and mastology in Germany.
    Hildebrandt T; Thiel FC; Fasching PA; Graf C; Bani MR; Loehberg CR; Schrauder MG; Jud SM; Hack CC; Beckmann MW; Lux MP
    Anticancer Res; 2014 Feb; 34(2):829-35. PubMed ID: 24511019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The construction of standard gamble utilities.
    van Osch SM; Stiggelbout AM
    Health Econ; 2008 Jan; 17(1):31-40. PubMed ID: 17410521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The development of a model for translation of the Neck Disability Index to utility scores for cost-utility analysis in cervical disorders.
    Richardson SS; Berven S
    Spine J; 2012 Jan; 12(1):55-62. PubMed ID: 22209244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A predictive model of health state utilities for HIV patients in the modern era of highly active antiretroviral therapy.
    Kauf TL; Roskell N; Shearer A; Gazzard B; Mauskopf J; Davis EA; Nimsch C
    Value Health; 2008 Dec; 11(7):1144-53. PubMed ID: 18494750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of health state utilities and quality of life in patients with malignant esophageal Dysphagia.
    Wildi SM; Cox MH; Clark LL; Turner R; Hawes RH; Hoffman BJ; Wallace MB
    Am J Gastroenterol; 2004 Jun; 99(6):1044-9. PubMed ID: 15180723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimation of utilities for chronic hepatitis C from SF-36 scores.
    Thein HH; Krahn M; Kaldor JM; Dore GJ
    Am J Gastroenterol; 2005 Mar; 100(3):643-51. PubMed ID: 15743364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of captopril therapy after myocardial infarction.
    Tsevat J; Duke D; Goldman L; Pfeffer MA; Lamas GA; Soukup JR; Kuntz KM; Lee TH
    J Am Coll Cardiol; 1995 Oct; 26(4):914-9. PubMed ID: 7560617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health state utilities of a population of Nigerian hypertensive patients.
    Ekwunife OI; Aguwa CN; Adibe MO; Barikpaoar E; Onwuka CJ
    BMC Res Notes; 2011 Dec; 4():528. PubMed ID: 22152124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cost-effectiveness of treatments of hypertension].
    Plans Rubió P
    Med Clin (Barc); 2000 Nov; 115(18):718. PubMed ID: 11141433
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of the symptoms of treated hypertensive patients.
    Bulpitt CJ; Dollery CT
    Methods Inf Med; 1979 Jan; 18(1):36-41. PubMed ID: 763165
    [No Abstract]   [Full Text] [Related]  

  • 40. Correction to: Different Methods for Modelling Severe Hypoglycaemic Events: Implications for Effectiveness, Costs and Health Utilities.
    Keeney E; Dawoud D; Dias S
    Pharmacoeconomics; 2019 Jul; 37(7):973. PubMed ID: 30850952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.